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ne characteristic linking members of the synap-
totagmin family to endocytosis is their ability to
bind the heterotetrameric AP2 complex via their
C2B domain. By using CD4/synaptotagmin 1 chimeras, we
found that the internalization signal of synaptotagmin 1
lies at the extreme COOH-terminus of the protein and can
function in the absence of the C2B domain that contains
the AP2 binding site. However, although not essential for
internalization, the C2B domain of synaptotagmin 1 ap-
peared to control the recognition of the internalization mo-
tif. By mutagenesis, two sites have been identiﬁed that
modify regulation by the C2B domain in the neuroendo-
 
crine PC12 cell line. Mutation of a dilysine motif in the 
 
 
O
 
sandwich core of the domain eliminates endocytosis. This
site is known to be a site of protein–protein interaction.
Mutations in the calcium binding region, or in its close
proximity, also affect internalization in PC12 cells. In ﬁbro-
blasts, the C2B domain inhibits the COOH-terminal inter-
nalization signal, resulting in an absence of internalization
in those cells. Thus, internalization of synaptotagmin 1 is
controlled by the presence of a latent internalization signal
in the COOH-terminal region and a regulatory region in
the C2B domain. We propose that internalization of synap-
totagmin 1 is regulated in this way to allow it to couple the
processes of endocytosis and calcium-mediated exocytosis
in cells of the neuroendocrine lineage.
 
Introduction
 
Several cell surface proteins have conserved internalization sig-
nals in their cytoplasmic domains. Such proteins become
cargo for the endocytotic machinery of cells when their inter-
 
nalization signals are recognized by the 
 
 
 
 or the 
 
 
 
 subunit of
heterotetrameric AP2 adaptors, which in turn bind clathrin
and several accessory proteins (Kirchhausen, 1999). AP2 bind-
ing to cargo can only be a part of the internalization process,
however, since the binding affinities are weak and the same
signals can also be recognized by the AP1 and AP3 adaptors to
mediate sorting from Golgi and endosomal membranes.
One additional family of proteins that participates in the
endocytotic process are the synaptotagmins, a family of pro-
teins primarily implicated in calcium-regulated exocytosis.
Up to 13 synaptotagmin isoforms have been isolated (Mat-
thew et al., 1981; Li et al., 1995; Babity et al., 1997; von
Poser et al., 1997; von Poser and Sudhof, 2000; Fukuda and
Mikoshiba, 2001). The best studied member of the family is
synaptotagmin 1, a neuronal isoform present on the mem-
branes of synaptic vesicles and secretory granules (Matthew
et al., 1981). Genetic evidence in 
 
Drosophila
 
, 
 
C. elegans
 
, and
mouse have implicated synaptotagmin 1 as an essential com-
ponent of fast calcium-dependent neurotransmitter release
(Littleton et al., 1993; Nonet et al., 1993; DiAntonio and
Schwarz, 1994; Geppert et al., 1994; Littleton et al., 1994;
Fernandez-Chacon et al., 2001; Littleton et al., 2001). Bio-
chemical properties of synaptotagmin 1 support the idea
that synaptotagmin 1 forms part of the calcium sensor in fast
exocytosis. Synaptotagmins are integral membrane proteins
that contain two calcium binding domains, C2A and C2B,
in their large cytoplasmic region (Perin et al., 1991; Sudhof
and Rizo, 1996). Calcium triggers binding of the C2A do-
main to phospholipids (Brose et al., 1992; Davletov and
Sudhof, 1993; Chapman and Jahn, 1994; Chapman and
Davis, 1998) as well as the clustering of synaptotagmin via
the C2B domain (Chapman et al., 1996; Sugita et al.,
1996). The two C2 domains cooperate to form complexes
with components of the SNARE machinery (Li et al., 1995;
Davis et al., 1999; Gerona et al., 2000), suggesting a model
in which synaptotagmin triggers exocytosis through its inter-
actions with membranes and the SNARE complex.
 
A role for synaptotagmin in endocytosis as well as exocy-
tosis was first suggested by the high affinity, calcium-inde-
pendent binding of the C2B domain to AP2 (Zhang et al.,
1994), one of the most conserved properties among the
synaptotagmin family (Li et al., 1995). Synaptotagmin 1
 
binds most tightly to a region of the 
 
 
 
 chain of AP2 that is
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distinct from the AP2 region that binds tyrosine-based in-
ternalization signals (Owen and Evans, 1998; Haucke et al.,
2000). Transfection experiments have confirmed that the
synaptotagmins play a major role in receptor-mediated en-
docytosis. In one set of experiments, expression of the
transmembrane domain of synaptotagmins reduced clath-
rin-coated pit formation and inhibited LDL uptake (von
Poser et al., 2000). This effect was dependent on the pres-
ence of two cysteines involved in synaptotagmin oligo-
merization. In a second set, disrupting the C2B–AP2 inter-
actions in vivo by expressing the synprint region of calcium
channels inhibited transferrin receptor internalization (Haucke
et al., 2000). Moreover, interaction among cargo proteins,
AP2, and synaptotagmin appears to be cooperative, since
the presence of a peptide containing a tyrosine-based inter-
nalization signal enhanced AP2 binding to synaptotagmin
in vitro (Haucke and De Camilli, 1999). Therefore, synap-
totagmins play a critical role in nucleating a coated pit–
containing cargo, AP2, and clathrin, even in nonneuronal
cells.
The brain-specific synaptotagmin 1 member of the synap-
totagmin family appears to exhibit tissue-specific endocyto-
sis, a relatively rare phenomenon. Although synaptotagmin
1 is readily internalized by the neuronal-like PC12 cells, in
transfected fibroblasts it was found mostly on the cell surface
(Feany et al., 1993). This suggested that cells of the neu-
roendocrine lineage possess an endocytotic mechanism lack-
ing in nonneuronal cells. To try to understand this mecha-
nism, we have examined the internalization of synaptotagmin
1 and its chimeras into neuronal and nonneuronal cell lines.
Surprisingly, the AP2 binding site in the C2B domain is not
needed for internalization of chimeras. By contrast, we find
evidence for an internalization signal in the COOH-termi-
nal domain of synaptotagmin 1. The internalization signal is
sufficient to mediate internalization of chimeras in the ab-
sence of the C2B domain, and can be recognized by the en-
docytotic machinery even in nonneuronal cells. The C2B
domain acts as a regulator of internalization since in fibro-
blast cells it normally conceals the synaptotagmin 1 internal-
ization signal. In PC12 cells, little inhibition of the COOH-
terminal internalization signal by the C2B domain is seen
unless mutations are made in the C2B domain, in particular
in a dilysine motif that has already been implicated in en-
docytosis by the synprint experiments of Haucke and De
Camilli (1999). Endocytosis of synaptotagmin 1 appears to
be controlled by a latent internalization signal that is acti-
vated by a neuroendocrine-specific mechanism acting via the
C2B domain. Thus, synaptotagmin 1 internalization resem-
bles ligand-activated endocytosis of surface receptors, except
that the activation is intracellular.
 
Results
 
Synaptotagmin 1 is not endocytosed in CHO cells
 
In previous studies of CHO cells transfected with synaptic
vesicle proteins, synaptophysin, VAMP2, and SV2 were tar-
geted to intracellular organelles (Linstedt and Kelly, 1991;
Feany et al., 1993; Grote and Kelly, 1996). In contrast, syn-
aptotagmin 1, when expressed in CHO cells, was detected
 
predominantly at the plasma membrane (Feany et al.,
1993). To determine whether CHO cells failed to internal-
ize synaptotagmin 1, we generated CHO cells stably trans-
fected with synaptotagmin 1 and developed a quantitative
assay of endocytosis using flow cytometry analysis. For this
assay, the pool of synaptotagmin 1 on the plasma membrane
was labeled at 4
 
 
 
C with the 604.1 antibody directed against
the lumenal domain of the protein. After warming to 37
 
 
 
C
for various times, the 604.1 antibody remaining at the cell
Figure 1. Comparison of synaptotagmin 1 internalization in CHO 
and PC12 cells. (a) wtPC12 or (b) CHO stably transfected with 
synaptotagmin 1 (CHOsyn1) were labeled at 4 C with the 604.1 
antibody and then moved to 37 C for the indicated periods. Cells 
were cooled to 4 C and antibody remaining at the surface after the 
37 C incubation was detected with a fluorescein-conjugated second-
ary antibody. The intensity of fluorescence was determined by flow 
cytometry. Data were expressed as the percentage of the initial value 
at t   0. (c) The expression level of synaptotagmin 1 in different 
CHOsyn1 clones was determined by flow cytometry after permeabi-
lization of the cells and staining with 604-1 antibody. These values 
are expressed along the x-axis. The same clones were then analyzed 
for internalization of synaptotagmin 1 using the same assay as in 
panels a and b. The values obtained after 10 min at 37 C corre-
spond to the y-axis. The same measurements were done in parallel 
on PC12 cells. (d) wt PC12, CHOsyn1, and HEK cells stably 
expressing synaptotagmin 1 (HEKsyn1) were examined for internal-
ization of synaptotagmin 1 using 
125I -604.1 antibody. Cells were 
labeled at 4 C and shifted to 37 C for different time points. The 
internalized antibody was determined by surface acid stripping and 
expressed as a fraction of total cell associated counts. Each time 
point was done in triplicate. In this and subsequent figures, when 
standard deviations are not apparent, they were too small to be rep-
resented graphically. 
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surface was detected by staining with a fluorescent anti-IgG
and quantified using flow cytometry. When measured in
PC12 cells, internalization of the endogenous synaptotag-
min 1 was rapid (Fig. 1 a). About 50% of 604.1 disappeared
from the cell surface within the first 5 min. This disappear-
ance was not due to a loss of antibody into the media, since
it could be detected inside the cells after permeabilization
(data not shown). In contrast, we could not detect signifi-
cant internalization of synaptotagmin 1 in stably transfected
CHO cells (Fig. 1 b), whereas transferrin internalization was
normal (data not shown). One possible explanation was that
the pathway for synaptotagmin 1 internalization can be satu-
rated at high expression levels
 
. 
 
We selected several clones
with relatively low expression levels. The total levels of ex-
pression were measured by flow cytometry after the staining
of permeabilized cells with 604.1 antibody followed by a flu-
orescent secondary antibody. We examined these same clones
in the internalization assay described above. Regardless of
the total level of expression, the amount of 604.1 remaining
at the surface after 10 min at 37
 
 
 
C was between 75 and
100% of the initial value, even in a clone whose expression
level matched that of PC12 (Fig. 1 c). That was in clear con-
trast with the result obtained in PC12 cells where 
 
 
 
40%
was detected at the surface after 10 min at 37
 
 
 
C. Our results
were confirmed using a conventional endocytosis assay based
on internalization of 
 
125
 
I-604.1 into an acid-resistant pool
(Fig. 1 d). Synaptotagmin 1 was not internalized when
transfected into CHO cells, or into human embryonic kid-
ney (HEK)* cells, another nonneuronal cell line. It thus ap-
pears as if nonneuronal cells lack some components or path-
ways involved in synaptotagmin 1 internalization.
 
Internalization of synaptotagmin 1 in PC12 cells is 
mediated by an internalization signal present in the 
COOH-terminal domain
 
The lack of internalization of synaptotagmin 1 in CHO cells
suggested that synaptotagmin 1 might be internalized by a
neuron-specific sorting motif recognized by components
present only in neurons. Since the C2B domain is known to
bind AP2 it might contain the internalization signal. The
AP2 binding site in the C2B domain has been mapped in a
region between residues 296 and 328 (Chapman et al.,
1998). To identify the cytoplasmic domain responsible for
internalization of synaptotagmin 1 in PC12 cells, we gener-
ated constructs containing the lumenal and transmembrane
domain of the CD4 molecule fused to different cytoplasmic
regions of synaptotagmin 1 (Fig. 2). Each construct was sta-
bly expressed in PC12 cells by retroviral infection and tested
for internalization using uptake of 
 
125
 
I -Q4120, a well char-
acterized antibody directed against the external part of CD4.
Cell surface CD4 was labeled at 4
 
 
 
C and the antibody was
allowed to internalize at 37
 
 
 
C for 10 min. Internalization of
 
125
 
I -Q4120 was assessed as acid-resistant bound antibody.
As expected from previous studies (Pelchen-Matthews et al.,
1991), a CD4 tailess construct was only poorly endocytosed
(Fig. 3 a). Its internalization was efficiently promoted by fu-
sion to the cytoplasmic domain of synaptotagmin 1 contain-
 
*Abbreviations used in this paper: HEK, human embryonic kidney; ML,
methione–leucine.
Figure 2. CD4–synaptotagmin 1 constructs. A CD4 tailess frag-
ment (human CD4 residues 1–426) was fused to different domains 
of the cytoplasmic region of rat synaptotagmin 1 to generate the 
following constructs: CD4-C2AB-CT (synaptotagmin 1 residues 
95–421), CD4-C2B-CT (synaptotagmin 1 residues 266–421), 
CD4-C2AB (synaptotagmin 1 residues 95–392), and CD4-CT 
(synaptotagmin 1 residues 393–421).
Figure 3. Internalization of CD4–synaptotagmin 1 constructs in 
PC12 cells. Cells stably transduced with retroviral vectors were 
surface labeled with 
125I -Q4120. Cells were then warmed to 37 C 
for 10 min and endocytosis was stopped by returning the cells to 
ice. The internalized 
125I -Q4120 antibody was quantitated as noted 
in the legend to Fig. 1 d, except that a background level obtained in 
cells kept at 4 C was subtracted. Error bars represent standard devi-
ation of triplicates in one representative experiment. (a) The COOH-
terminal domain of synaptotagmin 1 was necessary for endocytosis 
of CD4–synaptotagmin 1 constructs. (b) The COOH-terminal was 
sufficient to promote endocytosis of a CD4-CT construct. 
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ing the two C2 domains and the COOH-terminal region
(CD4-C2AB-CT).
The difference in the endocytotic rates in the presence and
absence of the cytoplasmic tail of synaptotagmin 1 allowed
us to initiate a mutagenesis study. Deleting the C2A domain
did not inhibit internalization (CD4-C2B-CT), but surpris-
ingly the C2B domain could not promote internalization
signal when the COOH-terminal region was removed
(CD4-C2AB), although the AP-2 binding site was intact.
Removal of the COOH-terminal region (CD4-C2AB) re-
duced internalization to a level close to that of the CD4 tail-
less construct. In contrast, the COOH-terminal region
alone, in the absence of C2A and C2B domains, was suffi-
cient to promote internalization of a CD4-CT construct
(Fig. 3 b). Kinetic analysis of internalization of the mutants
confirmed that the steady state measurements accurately re-
flect changes in the initial rates of internalization. We can
thus conclude that the AP2 binding site is not essential for
internalization of synaptotagmin 1. Instead, a strong inter-
nalization motif is present in the COOH-terminal domain
of synaptotagmin 1 that is necessary and sufficient for inter-
nalization.
We then examined whether the motifs that conformed to
known internalization signals in the COOH-terminal do-
main were responsible for synaptotagmin 1 internalization.
At present, two major groups of internalization motifs have
 
been described (Mellman, 1996; Kirchhausen et al., 1997),
tyrosine-based motifs and dileucine–based motifs in which
one of the leucines can be substituted by isoleucine, me-
thionine, or valine (Bremnes et al., 1994). The COOH-ter-
minal domain in our CD4-CT is composed of 29 amino ac-
ids, starting with an isoleucine–leucine motif (synaptotagmin
1 residues 393,394; Fig. 4 a). In a study of synaptic vesicle
targeting signals (Blagoveshchenskaya et al., 1999), internal-
ization of a CD4-CT construct lacking the isoleucine–leu-
cine motif was observed, showing that the motif is unlikely
to be part of the internalization signal. The COOH-termi-
nal domain contains a methione–leucine (ML) motif (syn-
aptotagmin 1 residues 416,417) that was shown to mediate
part of the synaptotagmin 1 targeting to synaptic-like mi-
crovesicles (Blagoveshchenskaya et al., 1999). The authors
reported that this motif was not acting at the step of synap-
totagmin 1 internalization. The ML motif is preceded by a
cluster of acidic residues. Acidic residues have been shown to
be involved in targeting events, either by themselves or in
combination with tyrosine or dileucine-based motifs (Mat-
ter et al., 1994; Pond et al., 1995; Voorhees et al., 1995;
Piguet et al., 2000). To assess the function of these putative
Figure 4. Mutagenesis of the putative internalization motifs 
within the COOH-terminal domain of synaptotagmin 1. (a) The 
29 amino acid sequence of the COOH-terminal domain of synap-
totagmin 1 is shown. The cluster of acidic residues, E410, 411, 
412, and D414, as well as the synaptic vesicle targeting signal, 
M416,L417, are indicated in bold type. (b) Changes to alanine 
were made in the CD4-C2AB-CT construct as follows: 
E410,411,412A to generate CD4-C2AB-CT(EEE/AAA), D414A to 
generate CD4-C2AB-CT(D/A), and M416A,L417A to generate 
CD4-C2AB-CT(ML/AA). Internalization of the constructs was 
assayed as in Fig. 3.
Figure 5. Internalization of CD4–synaptotagmin 1 constructs in 
CHO cells. Cells stably transduced with retroviral vectors were 
analyzed for internalization of 
125I -Q4120 antibody as in Fig. 3. 
(a) The C2AB-CT, C2B-CT, or C2AB domain of synaptotagmin 1 did 
not promote internalization of CD4–synaptotagmin 1 chimeras. 
(b) The COOH-terminal domain of synaptotagmin 1 did promote in-
ternalization when fused alone to the CD4 tailless molecule. 
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internalization signals, we substituted them for alanine resi-
dues in our CD4-C2AB-CT construct. Mutation of one
(D414A) or three (E410,411,412A) of the acidic residues
did not affect internalization of the CD4-C2AB-CT con-
struct (Fig. 4 b). Simultaneous mutation of M416A, L417A
also had no effect on internalization of the CD4-C2AB-CT
construct, thus confirming that the synaptic vesicle targeting
signal was not affecting synaptotagmin 1 internalization.
These results suggest the existence of an unconventional in-
ternalization signal in the COOH-terminal region of synap-
totagmin 1.
 
The C2B domain inhibits internalization in CHO cells
 
Synaptotagmin 1 was not internalized in CHO cells. Once
the COOH-terminal region was known to contain the inter-
nalization signal, we could test the hypothesis that it is spe-
cific for neuronal cells. To do this, the CD4-synaptotagmin
constructs were stably expressed in CHO cells using the
same retroviral system as the one used to transduce PC12
cells. Consistent with our previous observations showing
that synaptotagmin 1 was not endocytosed in CHO cells,
the CD4-C2AB-CT construct was not internalized (Fig. 5
a). Removal of the C2A or the CT domains did not affect
the retention of the constructs at the surface. In contrast, the
CD4-CT construct was very efficiently internalized, at levels
comparable to that obtained in PC12 cells (Fig. 5 b). This
result clearly indicates that the internalization signal present
in the COOH-terminal domain is efficiently recognized in
CHO cells, ruling out the hypothesis of a neuron-specific
internalization signal. Addition of the C2B domain was suf-
ficient to inhibit the function of the COOH-terminal inter-
nalization signal in CHO cells, since the CD4-C2B-CT
construct was not internalized (Fig. 5 a). This implied that
the C2B domain was a regulator of endocytosis, inhibiting
the internalization signal in CHO cells, but not in PC12
cells.
 
Mutations within the C2B domain affect endocytosis of 
synaptotagmin 1 in PC12 cells
 
Although the C2B domain is not needed for internalization,
we have found that mutations within it modify the internal-
ization process in PC12 cells, consistent with a role as a reg-
ulator. We have analyzed three sets of mutations in the C2B
domain by taking advantage of previous studies that exam-
ined oligomerization of synaptotagmin or its role in exocyto-
sis. The K326,327A mutation is known to affect several
C2B-mediated interactions, in particular AP2 binding and
calcium-mediated dimerization (Chapman et al., 1998).
The Y311N mutation was reported to inhibit calcium-medi-
ated conformational changes in the C2B and to reduce cal-
cium-mediated dimerization (Littleton et al., 2001). It lies
in close proximity to a set of conserved acidic calcium
ligands within the C2B domain (D303, 309, 363, 365, 371)
(Desai et al., 2000; Littleton et al., 2001). The Y311N mu-
tation corresponds to the AD3 mutation in 
 
Drosophila
 
 that
results in a postdocking defect in vivo. The D363,365N
mutation, which is believed to mimick the charge neutraliza-
tion induced by calcium binding, has been reported to pro-
mote constitutive dimerization of synaptotagmin 1 (Desai et
al., 2000). We introduced these mutations in the CD4/syn-
aptotagmin 1 constructs and tested the ability of the mu-
tants to be internalized in PC12 cells. We found that the
K326,327A mutation in the C2B domain dramatically re-
duced the extent of internalization (Fig. 6 a), even though
the domain is not required for internalization (Fig. 3 b).
This effect was seen in two independent constructs, CD4-
C2AB(K326/327A)-CT and CD4-C2B(K326/327A)-CT.
The inhibitory effect of the K326,327A mutation was con-
firmed in a kinetic experiment (Fig. 6 b). The mutation had
Figure 6. Effect of the K326,327A, Y311N, and D363,365N muta-
tions on internalization of CD4–synaptotagmin 1 chimeras. (a) 
PC12 transduced with retroviral vectors were assayed as in Fig. 3, 
and a ratio (R) of internal cpm divided by total cpm was calculated 
as before. The extent of inhibition (negative values) or stimulation 
(positive values) was calculated for each mutation as follows: R mu-
tation-Rwt/Rwt-RCD4 tailless. Results in panel a, represent the aver-
age of three independent experiments. The K326,327A mutation 
dramatically affected internalization of the CD4–synaptotagmin 1 
constructs in PC12 cells. (b) PC12 transduced with retroviral vectors 
were assayed as in Fig. 3, except that cells were left at 37 C for dif-
ferent periods of time. (c) CHO cells stably transduced were assayed 
as in Fig. 3. The K326,327A mutation had no effect in CHO cells. 
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no effect in CHO cells (Fig. 6 c), showing that the C2B re-
gion giving negative regulation in CHO cells is separate
from its AP2 binding site. The Y311N mutation had a par-
tial inhibitory effect on synaptotagmin 1 internalization in
PC12 cells (Fig. 6 a). The average extent of inhibition was
 
 
 
30%, whereas the K326,327A mutation inhibited to
 
 
 
80% (average calculated on three independent experi-
ments). Conversely, we observed a slight stimulation of in-
ternalization when the D363,365N mutation was present in
the CD4-C2B-CT construct and no effect within the con-
text of the CD4-C2AB-CT chimera (Fig. 6 a).
A GST/C2AB-CT fusion protein pulled down AP2 from
both PC12 and CHO cytosol (Fig. 7), indicating that the
different internalization properties of CHO and PC12 cells
are not due to a CHO-specific factor that prevents AP2
binding.
 
The internalization signal as well as the regulatory 
domain of synaptotagmin 1 function independently 
from the transmembrane region
 
Overexpression of the transmembrane domain of synap-
totagmins inhibits LDL receptor endocytosis (von Poser et
al., 2000). Although the effect was shown to be dependent
on two cysteines involved in synaptotagmin oligomeriza-
tion, the precise mechanism of the inhibitory effect is un-
known. This study suggested that the oligomerization via
the transmembrane region of synaptotagmins was impor-
tant for the assembly of clathrin-coated pits in nonneu-
ronal cells. Wild-type synaptotagmin 1 showed no detect-
able endocytosis into transfected CHO cells, whereas it
was efficiently internalized in PC12 cells (Fig. 1). Similar
results were found using CD4/synaptotagmin 1 constructs
lacking the transmembrane domain of synaptotagmin 1
(Figs. 3 a and 5 a). Thus, the transmembrane domain can-
not be important for the tissue-specific internalization of
the protein. To ask if recognition of the COOH-terminal
internalization signal was influenced by the nature of the
transmembrane domain in PC12 cells, constructs were
made that contained the lumenal domain of CD4 fused to
the transmembrane domain of synaptotagmin 1 and its dif-
ferent cytoplasmic regions (Fig. 8 a). We found again that
the COOH-terminal region was necessary and sufficient to
promote efficient internalization of the chimeras in PC12
cells (Fig. 8, b and c), whereas the K326,327A mutation
completely abolished internalization (Fig. 8 b). Thus, the
function of the COOH-terminal region as an internaliza-
tion signal, as well as the C2B domain as a regulatory re-
Figure 7. AP2 binding to synaptotagmin 1 in PC12 and CHO 
cells. Cell extracts were incubated with glutathione-agarose beads 
bound to GST or GST fused to the cytoplasmic domain of synap-
totagmin 1 (GST-syn). Material bound to the bead was eluted, sepa-
rated by SDS-PAGE electrophoresis, and analyzed by Western blot 
with an anti  -adaptin antibody (top). The bottom shows the GST-
syn protein as visible after Ponceau staining.
Figure 8. CD4–synaptotagmin 1 constructs containing the trans-
membrane domain of synaptotagmin 1. (a) The CD4 lumenal 
domain was fused to the transmembrane and cytoplasmic regions of 
synaptotagmin 1 to generate CD4-TM-C2AB-CT (synaptotagmin 1 
residues 53–421), CD4-TM-C2AB(K326,327A)-CT (same as 
CD4-TM-C2AB-CT but with the presence of the K326,327A muta-
tion), CD4-C2AB (synaptotagmin 1 residues 53–393) and CD4-TM-
CT (synaptotagmin 1 residues 53–94 and 393–421). As a control, a 
CD4-TM tailless construct (synaptotagmin 1 residues 53–94) was 
generated by introduction of a stop codon after residue 94 of synap-
totagmin 1; this construct contains the transmembrane domain of 
synaptotagmin 1 followed by the short proximal cytoplasmic 
domain. (b and c) PC12 transduced with retroviral vectors were 
assayed as in Fig. 3. The effects of the CT region and of the 
K326,327A mutation are independent of the presence of the trans-
membrane domain. 
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gion, is independent of the nature of the transmembrane
domain.
 
Discussion
 
This investigation was stimulated by puzzling observations
about the synaptotagmins. Synaptotagmin 1 did not get tar-
geted to internal compartments like other synaptic vesicle
proteins when transfected into fibroblasts, but instead accu-
mulated on the cell surface (Feany et al., 1993). We thought
that this might be due to an overexpression artifact that satu-
rated the endocytotic pathway in transfected cells, but this
was not so (Fig. 1 c). This rare example of cell type–specific
endocytosis suggested the involvement of neuroendocrine-
specific factors required for internalization in cells with regu-
lated secretory pathways. It makes sense that regulated secre-
tory cells might have a specialized endocytotic machinery to
handle compensatory endocytosis, which is the recovery of
secretory vesicle membranes after calcium-mediated exocy-
tosis (Jarousse and Kelly, 2001).
Our data suggest that the tissue specificity of synaptotag-
min 1 endocytosis is due to a regulatory mechanism that is
only activated in PC12 cells. Although synaptotagmins bind
AP2 (Zhang et al., 1994; Li et al., 1995), AP2 by itself can-
not explain the neuroendocrine specificity that we observe.
Indeed, AP2 is present in the cytosols of both fibroblasts and
PC12 cells and can bind to immobilized synaptotagmin tails
(Fig. 7). Moreover, the AP2 binding site does not act as an
internalization motif since its deletion did not inhibit inter-
nalization in PC12 cells (Fig. 3 b). Instead, the internaliza-
tion signal was found in the COOH-terminal region of the
protein (Fig. 3). In absence of the C2B domain, the COOH-
terminus internalization signal could promote endocytosis in
both PC12 and CHO cells (Figs. 3 b and 5 b). Thus, the tis-
sue specificity of synaptotagmin 1 internalization is not due
to a neuron-specific internalization motif, but to differences
in the accessibility of the internalization signal. This accessi-
bility appears to be controlled by the C2B domain, which to-
tally inhibits internalization in CHO cells (Fig. 5 a) and also
in PC12 cells when the oligomerization domain is inacti-
vated by the K326,327A mutation (Fig. 6). Internalization
in PC12 cells is also influenced, albeit more weakly, by the
calcium binding region of the C2B domain. A mutation that
inhibited calcium-mediated conformational changes (Y311N)
reduced endocytosis, while one that partially neutralizes the
charge (D363,365N) enhanced it (Fig. 6 a). The D363,365N
was reported to cause the C2B domain to dimerize as if it
had calcium bound (Desai et al., 2000).
C2 domains are usually thought to regulate membrane
traffic by their ability to sense changes in intracellular envi-
ronment, often with calcium levels, then trigger association
with membranes. Synaptic vesicle recycling has been shown
to be crucially dependent on the presence of synaptotagmin
(Jorgensen et al., 1995), particularly its C2B domain (Fukuda
et al., 1995b; Littleton et al., 2001). We propose that the
C2B domain acts as a sensor of intracellular changes in neu-
rons or neuroendocrine cells and couples these changes to
endocytosis by activating a novel internalization signal. A
plausible change that the C2B domain might sense is that a
calcium-mediated exocytotic event has occurred. The C2B
domain could detect such an event in several ways. The
K326,327 motif has been implicated in calcium-dependent
dimerization of synaptotagmin 1 (Chapman et al., 1998),
which in turn is thought to be required for exocytosis (Desai
et al., 2000). If calcium-mediated dimerization were also to
expose the COOH-terminal internalization domain, then
endocytosis would be elegantly coupled to exocytosis. Cal-
cium-mediated dimerization of synaptotagmin 1 cannot
fully explain the regulation of its endocytosis, however, since
the D363,365N mutation, which gives constitutive dimer-
ization (Desai et al., 2000), did not restore internalization in
CHO cells (data not shown). An alternative to calcium-
mediated dimerization activating internalization of synaptotag-
min 1 is binding via its dilysine motif to calcium channels
(Chapman et al., 1998), to phosphorylated phosphatidyl
inositides (Fukuda et al., 1995a), or to an unknown protein
on the plasma membrane. If any such interaction activates
the internalization signal, synaptotagmin 1 would only bind
coats after its arrival at the cell surface, not while a compo-
nent of an intracellular organelle. Since AP2 also binds to
the dilysine motif, an unattractive feature of these conjec-
tures is that they require the absence of AP2 in order to acti-
vate a coating step. AP2 binding could still play a significant
role if the neuroendocrine-specific factor activated endocy-
tosis when it interacted with AP2 bound to the C2B do-
main. Candidates for such AP2 binding factors abound and
include AP180 and the nerve-specific forms of endophilin,
syndapin, dynamin, and intersectin. Several of these factors
have been shown to cluster at “hot spots” on the plasma
membrane of nerve terminals (Estes et al., 1996; Gonzalez-
Gaitan and Jackle, 1997; Roos and Kelly, 1998) that are
sometimes adjacent to sites of exocytosis (Roos and Kelly,
1999). If they released an inhibition, this would provide a
mechanism for restricting synaptotagmin 1 internalization
to these specialized endocytotic zones. However, in prelimi-
nary experiments, cotransfection of CHO cells with synap-
totagmin and AP180 or dynamin 1 has not activated the in-
ternalization of synaptotagmin (data not shown). However,
an AP2 binding protein need not be cytoplasmic. A complex
of AP2 with a synaptic vesicle cargo protein could trigger in-
ternalization of synaptotagmin 1.
An earlier study suggested that oligomerization of synap-
totagmin via its transmembrane domain plays a role in for-
mation of clathrin-coated pits (von Poser et al., 2000). Since
our first series of constructs (Fig. 2) lacked this domain, we
generated a second series of chimeras (Fig. 8 a) to verify that
our observations were still true in the presence of the trans-
membrane domain of synaptotagmin 1. Our results clearly
show that the COOH-terminal region acts as an internaliza-
tion signal even in presence of the transmembrane domain,
and that the K326,327A mutation abolishes internalization.
A puzzling observation, though, is that the tailess construct
containing the synaptotagmin transmembrane domain was
internalized to a higher extent than the one containing the
CD4 transmembrane region (CD4-TM tailless and CD4
tailless, respectively; Fig. 8 b). A possible mechanism is that
the synaptotagmin transmembrane region forms oligomers
(von Poser et al., 2000) with the endogenous synaptotagmin
in PC12 cells, thus resulting in internalization of the CD4-
TM tailless via a piggy back mechanism. Alternatively, the 
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transmembrane and/or the short proximal cytoplasmic do-
main (to residue 94) may contain an additional weak inter-
nalization signal. Both transmembrane and COOH-terminal
signals are inhibited by the K326,327A mutation (Fig. 8 b).
Important questions remain about the role of the synap-
totagmins in nonneuronal cells. The COOH-terminal inter-
nalization signal of synaptotagmin 1 is recognized in fibro-
blasts by a machinery that cannot be cell type–specific. A
peptide that blocks the binding of AP2 to the C2B domain
of an endogenous synaptotagmin inhibited transferrin up-
take in fibroblasts (Haucke et al., 2000). One possible inter-
pretation is that the peptide used in this study inhibited an
activating region required for exposure of an internalization
signal. The synaptotagmins are now known to regulate exo-
cytosis in neuronal cells as well as nonneuronal ones (Mar-
tinez et al., 2000). Our data hint that they might also be
widespread regulators of endocytosis.
Our analysis reveals an unexpected complexity in synap-
totagmin 1 internalization, which is controlled by a mixture
of internalization and regulatory signals to give tissue-spe-
cific internalization. Another example of tissue-specific in-
ternalization was reported for a specific isoform of the Fc re-
ceptor family, FcRII-B1. In this case, a B cell–specific in
frame insertion into an internalization signal prevented the
lymphocytes from executing FcR-dependent antigen presen-
tation (Miettinen et al., 1989; Amigorena et al., 1992). Ex-
posure of latent endocytotic signals has been reported for re-
ceptor tyrosine kinases or G protein–coupled receptors that
undergo ligand-stimulated endocytosis (Ferguson, 2001).
The presence of a latent signal in synaptotagmin 1 and the
involvement of the synaptotagmins in both compensatory
endocytosis in the nerve terminals (Jorgensen et al., 1995)
and constitutive endocytosis in fibroblasts (Haucke et al.,
2000; von Poser et al., 2000) implies that these other forms
of endocytosis might also be regulated, perhaps via the C2B
domain of synaptotagmins. In contrast to ligand-stimulated
endcoytosis, however, the signals controlling endocytosis
rates are intracellular.
 
Materials and methods
 
Cell lines
 
PC12 cells were grown in DMEH-21 media supplemented with 10% horse
serum, 5% FCS, and penicillin-streptomycin. CHO cells were grown in
F12 media supplemented with 10% FCS and penicillin-streptomycin. HEK
cells and Phoenix cells (American Type Culture Collection) were grown in
DMEH-21 media supplemented with 10% FCS and penicillin-streptomycin.
 
Reagents and antibodies
 
The cDNA for rat synaptotagmin 1 was provided by Dr. Kathleen M. Buck-
ley (Harvard Medical School, Boston, MA). The pGEX–synaptotagmin 1
plasmid encoding the GST protein fused to the cytoplasmic region of rat
synaptotagmin 1 was a gift from Dr. Thomas C. Südhof (University of
Texas Southwestern Medical Center, Dallas, TX). The pcDNA3-CD4 and
pBMN-Z-I Neo plasmids were provided by Dr. Don Ganem (University of
California at San Francisco, San Francisco, CA).
Monoclonal antibody against the lumenal domain of synaptotagmin 1
(clone 604.1) was provided by Dr. R. Jahn (Goettingen, Germany). Mono-
clonal antibody against the external domain of the human CD4 (clone
Q4120) was obtained from the Medical Research Council AIDS Reagents Pro-
gram (National Institute for Biological Standards and Control). Anti–
 
 
 
-adaptin
antibody was purchased from Transduction Laboratories.
 
Constructs
 
The rat synaptotagmin 1 ORF was subcloned in the pcDNA3–hygro vector
(Invitrogen).
For the CD4-synaptotagmin constructs, a CD4 fragment (corresponding
to residues 1–426) encoding the lumenal, transmembrane, and 12 amino
acids of the cytoplasmic region of the human CD4 was amplified by PCR
from pcDNA3-CD4. The primers were chosen so that a SmaI restriction
site followed by a stop codon was added to the 3
 
 
 
 end of the CD4 frag-
ment. The PCR product was subcloned in the pCR3.1 vector (T/A cloning
kit; Stratagene), resulting in the pCR3.1-CD4 tailless plasmid. The cyto-
plasmic domains of synaptotagmin 1 were amplified by PCR from the
pGEX–synaptotagmin 1 plasmid to generate the following fragments:
C2AB-CT (encoding for residues 95–421), C2AB (residues 95–392), C2B-
CT (residues 266–421), and CT (residues 393–421). The forward primers
were flanked with a SmaI restriction site. The PCR products were sub-
cloned in the pCR3.1 vector. The synaptotagmin 1–encoding regions were
then cut out as SmaI-XhoI fragments and ligated to the corresponding sites
of the pCR3.1-CD4 tailless to generate in-frame CD4/synaptotagmin 1 chi-
meras. The resultant constructs were sequenced and the CD4/synaptotag-
min 1 ORFs were introduced as BamHI-XhoI fragments in the pBMN-Z-I-
Neo–derived vector. The K326,327A mutants were generated the same
way, except that the synaptotagmin 1 fragments were amplified from
pGEX–synaptotagmin 1-KK/AA plasmid, in which the K326,327A had
been introduced using a QuikChange site-directed mutagenesis kit (Strat-
agene). The other point mutations in the CD4-C2AB-CT and CD4-C2B-CT
constructs were generated by PCR using standard procedures. A synap-
totagmin 1 fragment containing the transmembrane and proximal cyto-
plasmic domain (corresponding to amino acids 53–94) was amplified by
PCR from the pcDNA3–synaptotagmin 1 vector and fused in frame by PCR
to the lumenal domain of the CD4 molecule (CD4 residues 1–394). The re-
sulting chimeric fragment was flanked with a BamH1 and a SmaI site at the
5
 
 
 
 and 3
 
 
 
 ends, respectively. The PCR product was subcloned as a BamH1-
SmaI fragment in the PCR3.1 plasmids either upstream of a stop codon to
generate the CD4-TM tailless construct (synaptotagmin 1 residues 53–94),
or upstream of the synaptotagmin 1 cytoplasmic domains to give the fol-
lowing constructs: CD4-TM-C2AB-CT (synaptotagmin 1 residues 53–421),
CD4-TM-C2AB (synaptotagmin 1 residues 53–392) and CD4-TM-CT (syn-
aptotagmin 1 residues 53–94 and 393–421). The SmaI restriction site used
to generate the TM-containing constructs resulted in an insertion of two
amino acids (P, G) between amino acid 94 and 95 of synaptotagmin 1. The
constructs were sequenced and a subsequent subcloning in the pBMN-Z-I-
Neo–derived vector was done as described above.
 
Transfections and retroviral infections
 
CHO and HEK cells were stably transfected with the pcDNA3–synaptotag-
min 1 vector using the Fugene-6 product according to the manufacturer’s
instructions (Boehringer). Cells were selected in the presence of 400 
 
 
 
g/ml
of hygromycin.
In initial experiments we tried to use transient transfectants to identify
sorting motifs. However, FACS analysis revealed an extremely high vari-
ability in the level of expression from cell to cell. Since our assays measure
the behavior of the transfected protein, they are heavily biased towards
cells with high expression levels. Since we were concerned about satura-
tion of sorting pathways in overexpressing cells, we chose instead the
route of retroviral infection that gives rise to moderate and homogenous
level of expression. For retroviral infections, we used a vector derived from
pBMN-Z-I-Neo in which the LacZ gene was deleted (fragments BamH1-SalI)
and replaced by our genes of interest (fragment BamHI-XhoI
 
 
 
containing
the CD4/synaptotagmin 1 ORFs). The vector contains the internal ribo-
some entry site of the encephalomyocarditis virus upstream of the neomy-
cin resistance gene. This permits both the gene of interest and the
neomycin resistance gene to be translated from a single bicistronic mRNA,
resulting in nearly all surviving colonies stably expressing the gene of in-
terest after selection with G418. Expression of the bicistronic mRNA is
controlled by the 5
 
 
 
 viral LTR promoter (Full length Moloney LTR). On
transfection of the vectors, the Phoenix-packaging cell line produces repli-
cation-defective viral particles that were used for stable gene transfer and
expression in PC12 and CHO cells. The Phoenix cells were transfected
with the different CD4–synaptotagmin 1 constructs using the Fugene-6
product. Virus-containing supernatants were filtered through a low binding
protein 0.45-
 
 
 
m filter (Pall Corporation) 48 h posttransfection, diluted with
4 
 
 
 
g/ml of hexadimethrine bromide (Sigma-Aldrich tailess), and used to in-
fect PC12 or CHO cells. After 12 h, the inoculum was replaced by fresh
media; 24–36 h later, 400 
 
 
 
g/ml of G418 was added. 10 d after infection,
colonies were pooled and propagated in culture in the presence of 400 
 
 
 
g/ 
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ml of G418. Cells were treated for 20 h before the experiments with 500
nM of trichostatin A to enhance expression of the constructs.
 
Flow cytometry analysis
 
For internalization assays, cells were detached by using enzyme-free/PBS-
based cell dissociation buffer (GIBCO BRL) according to the manufac-
turer’s instructions. Cells were incubated with 2 
 
 
 
g/ml of 604.1 antibody
in a saline solution (119 mM NaCl, 2.5 mM KCl, 2 mM CaCl
 
2
 
, 2 mM
MgCl
 
2
 
, 25 mM Hepes, pH 7.4, and 30 mM glucose) supplemented with
3% BSA for 60 min at 4
 
 
 
C. Cells were washed, incubated at 37
 
 
 
C for differ-
ent periods of time, and returned to 4
 
 
 
C to stop endocytosis. The 604.1 an-
tibody remaining at the surface was revealed by incubation at 4
 
 
 
C with a
fluorescein-conjugated anti–mouse antibody. Cells were analyzed with a
Becton Dickinson FACScalibur. The data were collected in a logarithmic
mode, and the geometric mean of fluorescence intensity was calculated.
To measure the expression level of synaptotagmin 1, cells were dissoci-
ated in enzyme-free buffer and fixed in 4% paraformaldehyde in PBS. An-
tibody incubations and washings were performed in PBS 1% BSA in the
presence of 0.02% saponin (Sigma-Aldrich). Cells were washed and
stained with 604.1 antibody. After washing, bound antibody was visual-
ized by addition of phycoerythrin-conjugated goat anti–mouse antibody.
Cells incubated with the secondary antibody alone served as negative con-
trols. Cells were analyzed by flow cytometry as mentioned above.
 
Internalization assays using iodinated antibodies
 
100 
 
 
 
g of 604.1 or 50 
 
 
 
g of Q4120 antibody was iodinated on iodogen-
coated tubes (Pierce Chemical Co.) as described (Clift-O’Grady et al.,
1998). Cells were plated on collagen and poly-
 
D
 
-lysine–coated 12-well
plates 2 d before the assay. Cells were incubated for 1 h at 4
 
 
 
C with 2 
 
 
 
g/
ml of 
 
125
 
I -604.1 antibody or 100 ng/ml of 
 
125
 
I-Q4120 in DMEH-21 media
supplemented with 1% BSA and 10 mM Hepes, pH 7.4. Unbound anti-
body was removed by extensive washes. Cells were next incubated at
37
 
 
 
C to allow endocytosis and then returned to 4
 
 
 
C. Antibody remaining at
the cell surface was removed by two 10-min washes at 4
 
 
 
C in PBS/BSA
supplemented with 30 mM glycine and adjusted to pH 2.4. Acid-resistant
antibody was collected by lysing the cells in 2 M NaOH. The fraction of
antibody internalized was calculated by dividing the acid wash–resistant
radioactive cpm by the sum of acid wash–resistant and –accessible cpm. A
background of acid-resistant counts in cells kept at 4
 
 
 
C was subtracted
from each value.
 
GST fusion protein pull down assay
 
The pGEX–synaptotagmin 1 plasmid was used to express the fusion protein
according to standard methods. GST control protein was generated by ex-
pression of the plasmid pGEX-3X (Amersham Pharmacia Biotech). GST fu-
sion proteins were bound to glutathione-agarose chromatography and sub-
jected to an extensive wash with intracellular buffer (38 mM potassium
aspartate, 20 mM potassium MOPS, pH 7.2, 5 mM reduced glutathione, 5
mM sodium carbonate, 2.5 mM magnesium sulfate). The washed beads
were used in a standard GST fusion protein binding assay. In brief, PC12 or
CHO cell extracts were obtained by lysis with 1% Triton X-100, 150 mM
NaCl, 10 mM Tris, pH 7.4, in the presence of proteases inhibitors. 40 
 
 
 
l of
saturated beads were incubated with 500 
 
 
 
g of cell extracts overnight at
4
 
 
 
C. Beads were washed extensively in the Triton X-100–containing buffer
and eluted with 20 mM glutathione in 120 mM NaCl, 50 mM Tris, pH 8,
for 30 min at room temperature. Proteins were then separated by SDS-
PAGE and assayed by Western blotting with an anti–
 
 
 
-adaptin antibody
used at 1:1,000.
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